BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 118 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.77 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $258,639 | +20.6% | 41,847 | -0.9% | 0.00% | – |
| Q1 2024 | $214,546 | -8.5% | 42,232 | +7.8% | 0.00% | – |
| Q4 2023 | $234,601 | -12.8% | 39,162 | +3.0% | 0.00% | – |
| Q3 2023 | $269,083 | +41.6% | 38,006 | +40.8% | 0.00% | – |
| Q2 2023 | $190,035 | -47.6% | 26,995 | -37.9% | 0.00% | -100.0% |
| Q1 2023 | $362,823 | -56.4% | 43,504 | -39.9% | 0.00% | -50.0% |
| Q4 2022 | $831,264 | +151.9% | 72,410 | +176.6% | 0.00% | +100.0% |
| Q3 2022 | $330,000 | +6.1% | 26,183 | -11.0% | 0.00% | 0.0% |
| Q2 2022 | $311,000 | -75.7% | 29,416 | -62.6% | 0.00% | -66.7% |
| Q1 2022 | $1,279,000 | +158.4% | 78,653 | +120.1% | 0.00% | +200.0% |
| Q4 2021 | $495,000 | -57.0% | 35,728 | -55.4% | 0.00% | -50.0% |
| Q3 2021 | $1,151,000 | -38.7% | 80,133 | -32.5% | 0.00% | -50.0% |
| Q2 2021 | $1,877,000 | +315.3% | 118,737 | +25.1% | 0.00% | +300.0% |
| Q2 2020 | $452,000 | -6.4% | 94,898 | +59.9% | 0.00% | -50.0% |
| Q1 2019 | $483,000 | -21.1% | 59,358 | -21.7% | 0.00% | 0.0% |
| Q4 2018 | $612,000 | +15200.0% | 75,830 | +12796.3% | 0.00% | – |
| Q2 2018 | $4,000 | +33.3% | 588 | 0.0% | 0.00% | – |
| Q1 2018 | $3,000 | 0.0% | 588 | 0.0% | 0.00% | – |
| Q4 2017 | $3,000 | 0.0% | 588 | 0.0% | 0.00% | – |
| Q3 2017 | $3,000 | +50.0% | 588 | +33.0% | 0.00% | – |
| Q2 2017 | $2,000 | -50.0% | 442 | 0.0% | 0.00% | – |
| Q1 2017 | $4,000 | +33.3% | 442 | 0.0% | 0.00% | – |
| Q4 2016 | $3,000 | +50.0% | 442 | 0.0% | 0.00% | – |
| Q3 2016 | $2,000 | +100.0% | 442 | 0.0% | 0.00% | – |
| Q2 2016 | $1,000 | -99.7% | 442 | -98.4% | 0.00% | -100.0% |
| Q3 2015 | $316,000 | – | 27,734 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 6,071,142 | $50,998,000 | 20.86% |
| RTW INVESTMENTS, LP | 3,458,120 | $29,048,000 | 7.65% |
| ISZO CAPITAL MANAGEMENT LP | 307,366 | $2,582,000 | 4.49% |
| DAFNA Capital Management LLC | 541,128 | $4,545,000 | 3.84% |
| RA Capital Management | 3,489,795 | $29,314,000 | 3.60% |
| EMORY UNIVERSITY | 375,348 | $3,153,000 | 2.98% |
| Ghost Tree Capital, LLC | 1,500,000 | $12,600,000 | 2.35% |
| ACUTA CAPITAL PARTNERS, LLC | 920,310 | $7,731,000 | 1.83% |
| Avoro Capital Advisors LLC | 1,603,001 | $13,465,000 | 1.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,085,236 | $25,916,000 | 1.00% |